The Biodefense Training Program is designed to prepare doctoral students for careers in a variety of research disciplines critical to protecting the US and other parts of the world from bioweapons and naturally emerging, highly pathogenic bacteria and viruses. The University of Texas Medical Branch is well qualified to provide this training by virtue of its state-of-the-art high containment facilities, major biodefense research programs, and outstanding faculty who study most of the major bioweapons. The research topics within the University of Texas Medical Branch biodefense portfolio are also unusually diverse, ranging from vaccine development to diagnostics to antimicrobial development to pathogenesis, and the programs are highly collaborative and interdisciplinary. The training program will focus on PhD students who are enrolled in three graduate programs: experimental pathology, microbiology and immunology, and biochemistry and molecular biology. Trainees will be selected by a committee after completion of the qualifying exam and will be supported for one to two years during their dissertation research. Fifteen senior, highly experienced faculty mentors will participate in the program, along with an additional 18 associate program faculty including both persons who provide specialized expertise and training, and junior faculty who will be eligible to mentor students with a Primary Faculty co-mentor. This latter arrangement is designed to develop junior faculty into effective graduate student mentors under the tutelage of experienced and accomplished senior faculty. Support for four trainees is requested.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Robbins, Christiane M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Medical Br Galveston
Schools of Medicine
United States
Zip Code
Andersson, Jourdan A; Sha, Jian; Kirtley, Michelle L et al. (2018) Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics. Antimicrob Agents Chemother 62:
Beck, Andrew S; Wood, Thomas G; Widen, Steven G et al. (2018) Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains. Sci Rep 8:13408
Barrows, Nicholas J; Campos, Rafael K; Liao, Kuo-Chieh et al. (2018) Biochemistry and Molecular Biology of Flaviviruses. Chem Rev 118:4448-4482
Burtnick, Mary N; Shaffer, Teresa L; Ross, Brittany N et al. (2017) Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis. Infect Immun :
Soong, Lynn; Shelite, Thomas R; Xing, Yan et al. (2017) Type 1-skewed neuroinflammation and vascular damage associated with Orientia tsutsugamushi infection in mice. PLoS Negl Trop Dis 11:e0005765
Tao, Pan; Mahalingam, Marthandan; Zhu, Jingen et al. (2017) A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis. Front Immunol 8:687
Manning, John T; Seregin, Alexey V; Yun, Nadezhda E et al. (2017) Absence of an N-Linked Glycosylation Motif in the Glycoprotein of the Live-Attenuated Argentine Hemorrhagic Fever Vaccine, Candid #1, Results in Its Improper Processing, and Reduced Surface Expression. Front Cell Infect Microbiol 7:20
Andersson, Jourdan A; Sha, Jian; Erova, Tatiana E et al. (2017) Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis. Front Cell Infect Microbiol 7:448
Agrawal, Anurodh Shankar; Tao, Xinrong; Algaissi, Abdullah et al. (2016) Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccin Immunother 12:2351-6
Bechelli, Jeremy; Smalley, Claire; Zhao, Xuemei et al. (2016) MyD88 Mediates Instructive Signaling in Dendritic Cells and Protective Inflammatory Response during Rickettsial Infection. Infect Immun 84:883-93

Showing the most recent 10 out of 87 publications